Chisato Ashida
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort study.
Journal: Scandinavian journal of rheumatology
Published: June 19, 2026
Diagnostic performance of HScore for macrophage activation syndrome complicating Still's disease in adults: a multicentre case-control study.
Journal: Rheumatology (Oxford, England)
Published: March 28, 2026
Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study.
Journal: Joint bone spine
Published: March 26, 2026
Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study.
Journal: Rheumatology (Oxford, England)
Published: April 22, 2025
Stepwise dose reduction and discontinuation of bDMARD in rheumatoid arthritis: a prospective cohort study of flare-free population, flares, and predictive markers.
Journal: Arthritis research & therapy
Published: April 20, 2025
Urinary Kim-1 Correlates with Interstitial Nephritis Activity in Patients with Microscopic Polyangiitis.
Journal: Current issues in molecular biology
Published: December 30, 2024
Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.
Journal: Arthritis research & therapy
Published: December 15, 2024
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.
Journal: Rheumatology (Oxford, England)
Published: November 15, 2024
Utility of the GerdQ questionnaire in detecting gastroesophageal symptoms with RA patients.
Journal: BMC rheumatology
Published: October 03, 2024
Blockade of IL-18Rα-mediated signaling pathway exacerbates neutrophil infiltration in imiquimod-induced psoriasis murine model.
Journal: Frontiers in medicine
Published: September 25, 2023
U-KIM-1 as a predictor of treatment response in lupus nephritis.
Journal: Lupus
Published: October 28, 2022
Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.
Journal: Frontiers in medicine
Published: December 18, 2020
Last Updated: 09/26/2026